CAS:66069-32-7|Clavulanic Acid 2-Amino-2,4,4-trimethylpentane Salt

CAS:66069-32-7|Clavulanic Acid 2-Amino-2,4,4-trimethylpentane Salt

Catalogue Number:C563755
Chemical Name:Clavulanic Acid 2-Amino-2,4,4-trimethylpentane Salt
Synonyms:[2R-(2α,3Z,5α)]-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, compd. with 2,4,4-Trimethyl-2-pentanamine (1:1); 2,4,4-Trimethyl-2-pentanamine (2R,3Z,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate; 2,4,4-Trimethyl-2-pentanamine [2R-(2α,3Z,5α)]-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
CAS Number:66069-32-7
Alternate CAS #
Free Acid: 58001-44-8
Molecular Formula:C₈H₉NO₅ . C ₈H₁₉N
Appearance:Pale Yellow Solid
Melting Point:>148°C (dec.)
Molecular Weight:199.16 + 129.24
Storage:-20°C, Hygroscopic
Solubility:DMSO (Slightly), Methanol (Slightly)
Category:Building Blocks; Miscellaneous;
Applications:Clavulanic Acid 2-Amino-2,4,4-trimethylpentane Salt is an intermediate in the synthesis of Clavulanic Acid Potassium Salt (C563750), a b-lactamase inhibitor, typically added to amoxicillin to increase its effectiveness.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References:Reading, C. and Cole, M.: Antimicrob. Ag. Chemother., 11, 852 (1977); Ball, A.P., et al.: Lancet, 1, 620 (1980); Brogden, R.N., et al. Drugs, 22, 337 (1981)
To ensure the stability of our products, the efficient express delivery service will be used. We also guarantee that the products will be shipped in the box with layers of tapes to protect them against damage. The extremely low temperature products will be wrapped with dried ice, and the low temperature products will be delivered with ice bags. As for the products stored at room temperature, they will not be packed with ice bags or dried ice. Taskcm is committed to providing cost-effective products that facilitate drug delivery with our customers.
Email:sales@ebclink.com

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *